- Home
- OBIO vs SPCE Comparison
OBIO vs SPCE Comparison
Compare OBIO & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- SPCE
- Stock Information
- Founded
- OBIO 2017
- SPCE 2017
- Country
- OBIO United States
- SPCE United States
- Employees
- OBIO N/A
- SPCE N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- SPCE Transportation Services
- Sector
- OBIO Health Care
- SPCE Consumer Discretionary
- Exchange
- OBIO Nasdaq
- SPCE Nasdaq
- Market Cap
- OBIO 200.1M
- SPCE 187.1M
- IPO Year
- OBIO N/A
- SPCE N/A
- Fundamental
- Price
- OBIO $4.88
- SPCE $6.64
- Analyst Decision
- OBIO Strong Buy
- SPCE Hold
- Analyst Count
- OBIO 4
- SPCE 6
- Target Price
- OBIO $15.75
- SPCE $25.50
- AVG Volume (30 Days)
- OBIO 53.8K
- SPCE 1.8M
- Earning Date
- OBIO 11-12-2024
- SPCE 11-06-2024
- Dividend Yield
- OBIO N/A
- SPCE N/A
- EPS Growth
- OBIO N/A
- SPCE N/A
- EPS
- OBIO N/A
- SPCE N/A
- Revenue
- OBIO $2,647,000.00
- SPCE $9,416,000.00
- Revenue This Year
- OBIO $12.39
- SPCE $0.78
- Revenue Next Year
- OBIO $120.99
- SPCE N/A
- P/E Ratio
- OBIO N/A
- SPCE N/A
- Revenue Growth
- OBIO N/A
- SPCE 93.74
- 52 Week Low
- OBIO $4.22
- SPCE $5.27
- 52 Week High
- OBIO $10.46
- SPCE $54.60
- Technical
- Relative Strength Index (RSI)
- OBIO 43.91
- SPCE 49.86
- Support Level
- OBIO $4.78
- SPCE $6.16
- Resistance Level
- OBIO $5.84
- SPCE $6.82
- Average True Range (ATR)
- OBIO 0.42
- SPCE 0.37
- MACD
- OBIO -0.04
- SPCE -0.01
- Stochastic Oscillator
- OBIO 24.24
- SPCE 37.06
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.